The circadian rhythm has been generally proposed as a tumor‐suppressive mechanism that is disrupted in cancers,14 the low frequencies of genomic alterations in core clock genes indicate that the circadian clock might be dysregulated at the gene expression level. The gene discussed is CLOCK; the disease is cancer.